Luminal toxins, inflammatory cytokines, and metabolites

Luminal toxins, inflammatory cytokines, and metabolites represent a heterogeneous collection of substances found within the gastrointestinal tract that contribute to local and systemic pathology (Source: PMID: 30361173). This group includes bacterial products like lipopolysaccharides (endotoxins), host-derived signaling molecules such as tumor necrosis factor-alpha and various interleukins, and metabolic waste products like indoxyl sulfate and ammonia (Source: PMID: 29243613). In conditions such as chronic kidney disease and inflammatory bowel disease, the accumulation or translocation of these agents across the intestinal barrier drives chronic inflammation and organ dysfunction (Source: PMID: 25051280). Therapeutic strategies targeting this collective group typically involve oral adsorbents or binders designed to physically sequester these molecules, thereby reducing their bioavailability and mitigating their deleterious effects on the host (Source: PMID: 22433987). Because this term encompasses a wide array of chemically distinct entities rather than a single receptor or enzyme, it is classified as a broad therapeutic category rather than a specific molecular target.

Other names

Gut-derived toxinsUremic toxinsPro-inflammatory mediatorsLuminal noxious agentsIntestinal metabolites

Physical adsorption and sequestration of diverse molecular species within the gastrointestinal tract or blood to prevent systemic absorption or local interaction with the intestinal mucosa (Source: PMID: 30361173).